Sharon Cunningham

In 2018, Sharon Cunningham along with Orlaith Ryan founded health care startup, Shorla Oncology, on a simple but powerful proposition: that cancer patients of all ages should receive the best form of treatment available to them. Determined to make a difference, Shorla Oncology developed four oncology drugs in its first seven years of operation. They all received FDA approval, a process that can take more than 12 years.

Sharon has more than 14 years in leadership roles in the pharmaceutical industry including leading EirGen Pharma’s finance function for seven years prior to founding Shorla Oncology. She is a PwC Qualified Chartered Accountant with an MBA from University College Dublin Michael Smurfit Graduate Business School and a BSc in Finance from University College Cork, Ireland She earned a Certificate in Healthcare Innovation from MIT & Harvard Medical School and a Certificate in Healthcare Leadership from Columbia University